Methodist Health System COVID-19 Patient Registry

Recruiting

• Conditions: COVID-19
• Interventions: Other: Treatment for COVID-19

• Registration Number: NCT04477889
• Lead Sponsor: Methodist Health System

Brief Summary

This is a prospective cohort observational registry study that will include data on all patients who are treated at MHS facilities for COVID-19.

Detailed Description

This is a prospective cohort observational registry study that will include data on all patients who are treated at MHS facilities for COVID-19. Data including, but not limited to demographics, comorbidities, medications, treatment, and clinical outcomes will be collected from February 2020 to December 2025. Subjects will undergo no additional tests or procedures as part of this registry study. All patient data will be obtained from the patient's electronic health records (EHR) of the hospital or clinic in a retrospective manner. The process for gathering the data will not influence treatment decisions. There will be no direct patient contact associated with inclusion in this registry study.

Study Timeline

• Study Start: 2020-06-20
• Study First Submitted: 2020-07-17
• Study First Submitted QC: 2020-07-17
• Study First Posted: 2020-07-20
• Status Verified: 2023-07
• Last Update Submitted: 2023-07-06
• Last Update Posted: 2023-07-10
• Primary Completion: 2025-12
• Study Completion: 2026-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Patient tested positive for COVID-19 (SARS-CoV-2)
• Patient sought care for COVID-19 at a MHS facility
• Aged 18 years or older

Exclusion Criteria

• Patient that do not have COVID-19
• Non-confirmed COVID-19 patients
• Aged 17 years or younger

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
COVID-19 Cohort	Treatment for COVID-19	Patients treated at MHS facilites for COVID-19
Synopsis for COVID Bariatric, Hepato-Biliary and Colorectal surgery study	Treatment for COVID-19	30 Day Mortality after surgery in patients with COVID19 infection who undergo elective bariatric, hepato-biliary and colorectal surgery. * Patients diagnosed with COVID-19 at the time of surgery up to seven days before surgery * Patients diagnosed with COVID-19 within 30 days after surgery

Primary Outcome Measures

Name	Time	Method
Clinical and survival outcomes	June 2020 - Dec 2025	Clinical and survival outcomes
Patient Characteristics	June 2020 - Dec 2025	Patient characteristics
Treatment Measures and Intervention strategies	June 2020 - Dec 2025	Treatment measures and intervention strategies

Trial Locations

Locations (1)

Clinical Research Institute Methodist Health System; 🇺🇸 Dallas, Texas, United States